FIELD: medicine. SUBSTANCE: method involves determining cytokines content in blood serum like interleykine 1β (IL 1β), antagonist to interleykine 1β receptors (A/IL 1β), interleykine 8 (IL 8), tumor necrosis factor α (TNF α). IL 1β level growing 7,8- fold under reference value being equal to 20,60±0,87 pg/ml, human A/IL β 5- fold under reference value being equal to 14±0,19 pg/ml, IL 8 growing 3,4- fold under reference value being equal to 19,33±1,39 pg/ml, TNF α level growing 2,6-fold under reference value being equal to 28,70±0,99 pg/ml in male patients; IL β level growing 9,6-fold under reference value being equal to 20,81±0,97 pg/ml, human A/IL β 13-fold under reference value being equal to 13,22±0,15 pg/ml, IL 8 growing 2,3-fold under reference value being equal to 28,88±0,82 pg/ml, TNF α level growing 2,4-fold under reference value being equal to 28,33±1,03 pg/ml in female patients, mild degree of chronic pancreatitis is considered to be the case. IL β level growing 12.5-fold under reference value being equal to 20,62±0,87 pg/ml, human A/IL β 10.4-fold under reference value being equal to 14±0,19 pg/ml, IL 8 growing 3.9-fold under reference value being equal to 19,33±1,39 pg/ml, TNF α level growing 2.6-fold under reference value being equal to 28,70±0,99 pg/ml in male patients; IL β level growing 12.9- fold under reference value being equal to 20,81±0,97 pg/ml, human A/IL β 13-fold under reference value being equal to 13,22±0,15 pg/ml, IL 8 growing 2.7-fold under reference value being equal to 28,88±0,82 pg/ml, TNF α level growing 2,3-fold under reference value being equal to 28,33±1,03 pg/ml in female patients, medium degree of chronic pancreatitis is considered to be the case. IL 1β level growing 14.2-fold under reference value being equal to 20,62±0,87 pg/ml,, human A/IL 1β 15-fold under reference value being equal to 14±0,19 pg/ml,, IL 8 growing 11.8-fold under reference value being equal to 19,33±1,39 pg/ml,, TNF α level growing 3.8- fold under reference value being equal to 28,70±0,99 pg/ml in male patients; IL 1β level growing 13,8-fold under reference value being equal to 13,22±0,15 pg/ml, human A/IL 1β 15-fold under reference value being equal to 20,81±0,97 pg/ml,, IL 8 growing 16.3-fold under reference value being equal to 28,88±0,82 pg/ml, TNF α level growing 3.3-fold under reference value being equal to 28,33±1,03 pg/ml in female patients, severe degree of chronic pancreatitis is considered to be the case. EFFECT: high accuracy of diagnosis; simplified method. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MULTIPLE THERAPY OF CHRONIC PANCREATITIS | 2001 |
|
RU2178304C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DISTINGUISHING CHRONIC PANCREATITIS CASES OF ALCOHOLIC AND BILIARY ETIOLOGY | 2005 |
|
RU2302003C1 |
METHOD OF DIAGNOSING CHRONIC PANCREATITIS OF ALCOHOLIC ETIOLOGY | 2016 |
|
RU2618401C1 |
METHOD FOR DIAGNOSTICS OF PROFESSIONAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FORMED UNDER CONDITIONS OF ACTION OF TOXIC INDUSTRIAL AEROSOLS | 2016 |
|
RU2613164C1 |
METHOD OF ASSESSMENT OF LOCAL INFLAMMATION ACTIVITY WITH UNDERLYING UTERINE CERVICAL DISEASES | 2009 |
|
RU2405145C1 |
METHOD FOR DIAGNOSTICS OF PROFESSIONAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FORMED UNDER CONDITIONS OF DUST ACTION | 2016 |
|
RU2619861C1 |
METHOD FOR PREDICTING PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES DURING PREGNANCY | 2021 |
|
RU2770106C1 |
METHOD OF TREATING PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS | 2013 |
|
RU2556577C1 |
METHOD OF TREATING PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2495687C1 |
METHOD FOR PREDICTION OF INTRAUTERINE FETAL INFECTION | 2008 |
|
RU2382361C1 |
Authors
Dates
2003-02-27—Published
2001-05-21—Filed